chr12-48107378-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001354735.1(PFKM):c.5A>T(p.His2Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 1,593,076 control chromosomes in the GnomAD database, including 40,698 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 4676 hom., cov: 32)
Exomes 𝑓: 0.20 ( 36022 hom. )
Consequence
PFKM
NM_001354735.1 missense
NM_001354735.1 missense
Scores
1
15
Clinical Significance
Conservation
PhyloP100: -1.24
Genes affected
PFKM (HGNC:8877): (phosphofructokinase, muscle) Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=6.336159E-5).
BP6
Variant 12-48107378-A-T is Benign according to our data. Variant chr12-48107378-A-T is described in ClinVar as [Benign]. Clinvar id is 441153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-48107378-A-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.573 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PFKM | NM_001354735.1 | c.5A>T | p.His2Leu | missense_variant | 2/26 | NP_001341664.1 | ||
PFKM | NM_001354736.1 | c.5A>T | p.His2Leu | missense_variant | 2/26 | NP_001341665.1 | ||
PFKM | NM_001166686.2 | c.5A>T | p.His2Leu | missense_variant | 2/25 | NP_001160158.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PFKM | ENST00000642730.1 | c.5A>T | p.His2Leu | missense_variant | 2/26 | ENSP00000496597.1 | ||||
PFKM | ENST00000340802.12 | c.5A>T | p.His2Leu | missense_variant | 2/25 | 2 | ENSP00000345771.6 | |||
PFKM | ENST00000549366.5 | c.5A>T | p.His2Leu | missense_variant | 2/7 | 4 | ENSP00000449622.1 |
Frequencies
GnomAD3 genomes AF: 0.227 AC: 34536AN: 152004Hom.: 4665 Cov.: 32
GnomAD3 genomes
AF:
AC:
34536
AN:
152004
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.282 AC: 65970AN: 234192Hom.: 12355 AF XY: 0.271 AC XY: 34712AN XY: 128232
GnomAD3 exomes
AF:
AC:
65970
AN:
234192
Hom.:
AF XY:
AC XY:
34712
AN XY:
128232
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.198 AC: 284596AN: 1440954Hom.: 36022 Cov.: 29 AF XY: 0.200 AC XY: 143833AN XY: 717684
GnomAD4 exome
AF:
AC:
284596
AN:
1440954
Hom.:
Cov.:
29
AF XY:
AC XY:
143833
AN XY:
717684
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.227 AC: 34574AN: 152122Hom.: 4676 Cov.: 32 AF XY: 0.237 AC XY: 17606AN XY: 74376
GnomAD4 genome
AF:
AC:
34574
AN:
152122
Hom.:
Cov.:
32
AF XY:
AC XY:
17606
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
594
ALSPAC
AF:
AC:
629
ESP6500AA
AF:
AC:
714
ESP6500EA
AF:
AC:
1217
ExAC
AF:
AC:
31472
Asia WGS
AF:
AC:
1574
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glycogen storage disease, type VII Benign:3
Benign, criteria provided, single submitter | clinical testing | Pars Genome Lab | Jul 01, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 30, 2023 | - - |
not provided Benign:2Other:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;.;N;N
REVEL
Benign
Sift
Benign
T;T;T;.;T;T
Sift4G
Pathogenic
D;D;D;.;D;D
Vest4
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at